Secular trends in the prognostic factors for papillary thyroid cancer

European Journal of Endocrinology

Volumn 171, Issue 5, 2014, Pages 667-675

  Choi, Hoonsung ^a   Lim, Jung Ah ^a   Ahn, Hwa Young ^b   Cho, Sun Wook ^a,c   Lee, Kyu Eun ^a   Kim, Kyung Won ^a   Yi, Ka Hee ^a   Sung, Myung Whun ^a   Youn, Yeo Kyu ^a,c   Chung, June Key ^a   Park, Young Joo ^a   Park, Do Joon ^a   Cho, Bo Youn ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c National Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SOUTH KOREA; THYROID PAPILLARY CARCINOMA; TREND STUDY; TUMOR VOLUME; AGED; CARCINOMA; EPIDEMIOLOGY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RISK FACTOR; THYROID NEOPLASMS; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEOUL; THYROID NEOPLASMS; TIME FACTORS;

EID: 84910116980     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0225     Document Type: Article

References (22)

1. Lin J-D, Chen S-T, Hsueh C & Chao T-C. A 29-year retrospective review of papillary thyroid cancer in one institution. Thyroid 2007 17 535-541. (doi:10.1089/thy.2006.0160)
2. Jung K-W, Won Y-J, Kong H-J, Oh C-M, Seo HG & Lee J-S. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Research and Treatment 2013 45 1. (doi:10.4143/crt.2013.45.1.1)
3. Eustatia-Rutten CFA, Corssmit EPM, Biermasz NR, Pereira AM, Romijn JA & Smit JW. Survival and Death Causes in Differentiated Thyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism 2006 91 313-319. (doi:10.1210/jc.2005-1322)
4. Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, Kim KW, Yi KH, Chung J-K, Youn YK et al. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid 2013 23 797-804. (doi:10.1089/thy.2012.0329)
5. Hamzany Y, Soudry E, Strenov Y, Lipschitz N, Segal K, Hadar T, Hilly O & Feinmesser R. Early death from papillary thyroid carcinoma. American Journal of Otolaryngology 2012 33 104-108. (doi:10.1016/j.amjoto.2011.04.002)
6. Tzvetov G, Hirsch D, Shraga-Slutzky I, Weinstein R, Manistersky Y, Kalmanovich R, Lapidot M, Grozinsky-Glasberg S, Singer J, Sulkes J et al. Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease. Thyroid 2009 19 487-494. (doi:10.1089/thy.2008.0228)
7. Sipos JA & Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clinical Oncology 2010 22 395-404. (doi:10.1016/j.clon.2010. 05.004)
8. Davies L & Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 2006 295 2164-2167. (doi:10.1001/jama.295.18.2164)
9. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G et al. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 5 years? Study on 4187 patients from a single Italian institution to answer this question. Journal of Clinical Endocrinology and Metabolism 2010 95 1516-1527. (doi:10.1210/jc.2009-1536)
10. Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW et al. The impact of age and gender on papillary thyroid cancer survival. Journal of Clinical Endocrinology and Metabolism 2012 97 E878-E887. (doi:10.1210/jc.2011-2864)
11. Mazurat A, Torroni A, Hendrickson-Rebizant J, Benning H, Nason RW & Pathak KA. The age factor in survival of a population cohort of welldifferentiated thyroid cancer. Endocrine Connections 2013 2 154-160. (doi:10.1530/EC-13-0056)
12. Konturek A, Barczyński M, Nowak W & Richter P. Prognostic factors in differentiated thyroid cancer - a 20-year surgical outcome study. Langenbeck's Archives of Surgery 2012 397 809-815. (doi:10.1007/s00423-011-0899-z)
13. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS & Sturgeon C. Extent of surgery affects survival for papillary thyroid cancer. Annals of Surgery 2007 246 375-384. (doi:10.1097/SLA.0b013e31814697d9)
14. Rahbari R, Zhang L & Kebebew E. Thyroid cancer gender disparity. Future Oncology 2010 6 1771-1779. (doi:10.2217/fon.10.127)
15. ChenGG,Vlantis AC, ZengQ&van HasseltCA. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Current Cancer Drug Targets 2008 8 367-377. (doi:10.2174/156800908785133150)
16. Kumar A, Klinge CM & Goldstein RE. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors a and b. International Journal of Oncology 2010 36 1067-1080.(doi:10.3892/ijo-00000588)
17. Steele SR, Martin MJ, Mullenix PS, Azarow KS & Andersen CA. The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Archives of Surgery 2005 140 981-985. (doi:10.1001/archsurg.140.10.981)
18. Mazzaferri EL & Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal ofMedicine 1994 97 418-428. (doi:10.1016/0002-9343(94)90321-2)
19. Egner JR. AJCC cancer staging manual. Journal of the American Medical Association 2010 304 1726. (doi:10.1001/jama.2010.1525)
20. Pellegriti G, Frasca F, Regalbuto C, Squatrito S & Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of Cancer Epidemiology 2013 2013 1-10. (doi:10.1155/2013/965212)
21. Enewold LR, Zhou J, Devesa SS, de Gonzalez AB, Anderson WF, Zahm SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF et al. Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004. Cancer Epidemiology, Biomarkers & Prevention 2011 20 2369-2376. (doi:10.1158/1055-9965.EPI-11-0596)r Epidemiology, Biomarkers & Prevention 2011 20 2369-2376. (doi:10.1158/1055-9965.EPI-11-0596)
22. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 1167-1214. (doi:10.1089/thy.2009.0110)